CHEPLAPHARM Arzneimittel GmbH
support_agent

Your contact persons

Archive Press releases

01/15/2014

CHEPLAPHARM continues its rapid growth: 50% sales increase in 2013 compared to the previous year.

more chevron_right
Archive

12/31/2012

CHEPLAPHARM acquires the rights for VESANOID® and ROHYPNOL® - largest investment since company´s existence.

more chevron_right
Archive

09/01/2010

CHEPLAPHARM attains the rights for HEMINEVRIN®/DISTRANEURIN®

more chevron_right
Back to top expand_less